Unbiased Proteomic and Transcript Analyses Reveal that Stathmin-1 Silencing Inhibits Colorectal Cancer Metastasis and Sensitizes to 5-Fluorouracil Treatment
Open Access
- 1 December 2014
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 12 (12) , 1717-1728
Abstract
Colorectal cancer metastasis is a major cause of mortality worldwide, which may only be controlled with novel methods limiting tumor dissemination and chemoresistance. High stathmin-1 (STMN1) expression was previously established as a hallmark of colorectal cancer progression and predictor of poor survival; however, the mechanism of action is less clear. This work demonstrates that STMN1 silencing arrests tumor-disseminative cascades by inhibiting multiple metastatic drivers, and repressing oncogenic and mesenchymal transcription. Using a sensitive iTRAQ labeling proteomic approach that quantified differential abundance of 4562 proteins, targeting STMN1 expression was shown to reinstate the default cellular program of metastatic inhibition, and promote cellular adhesion via amplification of hemidesmosomal junctions and intermediate filament tethering. Silencing STMN1 also significantly improved chemoresponse to the classical colorectal cancer therapeutic agent, 5FU, via a novel caspase-6 (CASP6)–dependent mechanism. Interestingly, the prometastatic function of STMN1 was independent of p53 but required phosphorylations at S25 or S38; abrogating phosphorylative events may constitute an alternative route to achieving metastatic inhibition. These findings establish STMN1 as a potential target in antimetastatic therapy, and demonstrate the power of an approach coupling proteomics and transcript analyses in the global assessment of treatment benefits and potential side-effects. Implications: Stathmin-1 is a potential candidate in colorectal cancer therapy that targets simultaneously the twin problems of metastatic spread and chemoresistance. Mol Cancer Res; 12(12); 1717–28. ©2014 AACR.Keywords
All Related Versions
This publication has 30 references indexed in Scilit:
- Regulatory networks defining EMT during cancer initiation and progressionNature Reviews Cancer, 2013
- CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasionInternational Journal of Oncology, 2012
- Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal TransitionJournal of Biological Chemistry, 2012
- Redox-Induced Src Kinase and Caveolin-1 Signaling in TGF-β1-Initiated SMAD2/3 Activation and PAI-1 ExpressionPLOS ONE, 2011
- Direct reprogramming of stem cell properties in colon cancer cells by CD44The EMBO Journal, 2011
- Transcriptional down‐regulation of Brca1 and E‐cadherin by CtBP1 in breast cancerMolecular Carcinogenesis, 2011
- Stathmin Regulates Centrosomal Nucleation of Microtubules and Tubulin Dimer/Polymer PartitioningMolecular Biology of the Cell, 2009
- Nuclear Speckle-Associated Protein Pnn/DRS Binds to the Transcriptional Corepressor CtBP and Relieves CtBP- Mediated Repression of the E-Cadherin GeneMolecular and Cellular Biology, 2004
- HIP1 and HIP1r Stabilize Receptor Tyrosine Kinases and Bind 3-Phosphoinositides via Epsin N-terminal Homology DomainsJournal of Biological Chemistry, 2004
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989